Your browser doesn't support javascript.
loading
Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial.
Petrelli, F; Rulli, E; Labianca, R; Lonardi, S; Rosati, G; Dotti, K; Ronzoni, M; Pella, N; Pusceddu, V; Banzi, M; Zampino, M G; Yasmina, M; Marchetti, P; Cantore, M; Zaniboni, A; Rimassa, L; Ciuffreda, L; Ferrari, D; Zagonel, V; Maiello, E; Sobrero, A.
Afiliação
  • Petrelli F; Medical Oncology Unit, Treviglio, Caravaggio Hospital, Treviglio, Bergamo, Italy. Electronic address: faupe@libero.it.
  • Rulli E; Laboratory of Methodology for Clinical Research, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Labianca R; Cancer Center ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Lonardi S; Medical Oncology Unit 1, Istituto Oncologico Veneto - IRCCS, Padua, Italy.
  • Rosati G; Medical Oncology Unit, Ospedale San Carlo, Potenza, Italy.
  • Dotti K; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Ronzoni M; Medical Oncology Unit, Ospedale San Raffaele - IRCCS, Milan, Italy.
  • Pella N; Medical Oncology Unit, Azienda Ospedaliero Universitaria Santa Maria della Misericordia, Udine, Italy.
  • Pusceddu V; Medical Oncology, University Hospital and University of Cagliari, Cagliari, Italy.
  • Banzi M; Medical Oncology Unit, AUSL-IRCCS, Reggio Emilia, Italy.
  • Zampino MG; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumours, IRCCS, Milan, Italy.
  • Yasmina M; Medical Oncology Unit, Rovigo Hospital, Rovigo, Italy.
  • Marchetti P; Medical Oncology Unit, Sant'Andrea Hospital, Sapienza University of Rome and IDI-IRCCS, Rome, Italy.
  • Cantore M; Medical Oncology Unit, ASST Mantova, Mantua, Italy.
  • Zaniboni A; Medical Oncology Unit, Fondazione Poliambulanza, Brescia, Italy.
  • Rimassa L; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center-IRCCS, Rozzano (MI); Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy.
  • Ciuffreda L; Medical Oncology Unit, Azienda Ospedaliero Universitaria San Giovanni Battista, Molinette, Turin, Italy.
  • Ferrari D; Medical Oncology Unit, Azienda Ospedaliera San Paolo, Milan, Italy.
  • Zagonel V; Medical Oncology Unit 1, Istituto Oncologico Veneto - IRCCS, Padua, Italy.
  • Maiello E; Medical Oncology Unit, Hospital Casa Sollievo della Sofferenza-IRCCS, San Giovanni Rotondo, Italy.
  • Sobrero A; Medical Oncology Unit, IRCCS San Martino-IST, Genoa, Italy.
Ann Oncol ; 32(1): 66-76, 2021 01.
Article em En | MEDLINE | ID: mdl-33098997
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fluoruracila / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fluoruracila / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article